Latest Breaking News On - Cardiff oncology - Page 1 : comparemela.com

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial
bmj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bmj.com Daily Mail and Mail on Sunday newspapers.

United statesEteläuomen läiSouth koreaJin wangGenentechf hoffmannAsher biotherapeuticsDaiichi sankyoChipscreen biosciencesBristol myers squibbAshfield medcommsMerck biopharmMerck seronoSamsung bioepisLyell immunopharmaCalithera biosciencesEli lilly

Cardiff Oncology to Present at Upcoming Investor Conferences in May

Cardiff Oncology to Present at Upcoming Investor Conferences in May
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMark erlanderKiki patelJames levineGilmartin groupTaft communicationsCardiff oncology incAnnual bioconnect investor conferenceNasdaq headquartersAnnual oncology innovation summitCardiff oncologyOncology contact

Critical Analysis: Cardiff Oncology (NASDAQ:CRDF) & Finch Therapeutics Group (NASDAQ:FNCH)

Critical Analysis: Cardiff Oncology (NASDAQ:CRDF) & Finch Therapeutics Group (NASDAQ:FNCH)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoSkysong innovationsCardiff oncology incTakeda pharmaceutical companyFinch therapeutics groupFinch therapeutics group incTrovagene incUniversity of minnesotaCardiff oncologyGet free reportFinch therapeuticsGiven cardiff oncologyPolo like kinaseTherapeutics groupTakeda pharmaceutical company limited

HC Wainwright Reiterates Buy Rating for Cardiff Oncology (NASDAQ:CRDF)

HC Wainwright Reiterates Buy Rating for Cardiff Oncology (NASDAQ:CRDF)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerCardiff oncology company profileBlair william coCallan capitalCardiff oncology incCardiff oncologyFree reportGet free reportPolo like kinaseCardiff oncology daily

FN Media Group: Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036

FN Media Group: Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesThomas bockMatt coffeyMark erlanderAnna berkenblitJosh smileyDirk arnoldThomas heinemanResearch nesterAmerican society of clinical oncologyZai labFn media groupClinical cancer researchSecurities exchangeExchange commissionCardiff oncology inc